Dan Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dan Yu has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
Lu Lu
Laboratory of Infection and Microbiology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Key Laboratory of Major Diseases in Children, Ministry of Education National Center for Children's Health Beijing China
4 shared publicationsMiao Fan
Laboratory of Infection and Microbiology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Key Laboratory of Major Diseases in Children, Ministry of Education National Center for Children's Health Beijing China
4 shared publicationsXinyu Wang
Laboratory of Infection and Microbiology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, Key Laboratory of Major Diseases in Children, Ministry of Education, National Center for Children’s Health, Beijing, China
4 shared publications- Kaihu Yao
Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Pediatrics, Laboratory of Infection and Microbiology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health , Beijing
3 shared publications - Lei Jia
State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing 100071, China
3 shared publications Wen Su
Laboratory of Infection and Microbiology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Key Laboratory of Major Diseases in Children, Ministry of Education National Center for Children's Health Beijing China
3 shared publications
Latest Publications
- Open Access
- 17 August 2026
- Published by Wiley in World Journal of Otorhinolaryngology - Head and Neck Surgery
Herpesvirus and Adenotonsillar Hypertrophy in Chinese Children: An Epidemiological and Clinical Analysis
Objective: To investigate the possible association between adenotonsillar hypertrophy (ATH) and herpesviral infections in children, and to examine correlations between specific viral detection and clinical characteristics. Methods: We enrolled 43 children aged 3–14 years with ATH (mean age 76.56 ± 25.65 months; 31 boys). Paired tonsil and adenoid specimens were collected during non‐acute infection periods, defined as the absence of fever (body temperature < 37.3°C), purulent tonsillar exudate, or new‐onset respiratory symptoms within 2 weeks before surgery. Eight human herpesviruses (HHVs) were detected by qualitative real‐time polymerase chain reaction (qPCR), and associations with demographic, clinical, and polysomnographic variables were explored. Results: The overall HHV detection rate was 97.7% (42/43). Epstein–Barr virus (EBV), HHV‐6, and HHV‐7 were the most prevalent in both tissues, with detection rates of 44.2%, 74.4%–79.0%, and 65.1%–67.5%, respectively. EBV DNA positivity in both tissue types was associated with older age, longer disease duration, and a lower arousal index (AI) (all p < 0.05). HHV‐6 DNA positivity in tonsils was correlated with longer disease duration ( p = 0.006), whereas HHV‐7 DNA positivity in adenoids was associated with larger adenoid size ( p = 0.012). No significant differences were identified between monoviral and multiviral groups. Conclusion: EBV, HHV‐6, and HHV‐7 are highly prevalent in pediatric ATH tissues and associate with select clinical parameters, yet viral positivity did not correlate with disease severity. These findings do not support routine viral screening or changes in clinical management for ATH. The role of herpesviruses in ATH pathogenesis warrants further investigation through controlled, longitudinal studies.
- 17 August 2026
- Published by Wiley in World Journal of Otorhinolaryngology - Head and Neck Surgery
Open AccessHerpesvirus and Adenotonsillar Hypertrophy in Chinese Children: An Epidemiological and Clinical Analysis
Objective: To investigate the possible association between adenotonsillar hypertrophy (ATH) and herpesviral infections in children, and to examine correlations between specific viral detection and clinical characteristics. Methods: We enrolled 43 children aged 3–14 years with ATH (mean age 76.56 ± 25.65 months; 31 boys). Paired tonsil and adenoid specimens were collected during non‐acute infection periods, defined as the absence of fever (body temperature < 37.3°C), purulent tonsillar exudate, or new‐onset respiratory symptoms within 2 weeks before surgery. Eight human herpesviruses (HHVs) were detected by qualitative real‐time polymerase chain reaction (qPCR), and associations with demographic, clinical, and polysomnographic variables were explored. Results: The overall HHV detection rate was 97.7% (42/43). Epstein–Barr virus (EBV), HHV‐6, and HHV‐7 were the most prevalent in both tissues, with detection rates of 44.2%, 74.4%–79.0%, and 65.1%–67.5%, respectively. EBV DNA positivity in both tissue types was associated with older age, longer disease duration, and a lower arousal index (AI) (all p < 0.05). HHV‐6 DNA positivity in tonsils was correlated with longer disease duration ( p = 0.006), whereas HHV‐7 DNA positivity in adenoids was associated with larger adenoid size ( p = 0.012). No significant differences were identified between monoviral and multiviral groups. Conclusion: EBV, HHV‐6, and HHV‐7 are highly prevalent in pediatric ATH tissues and associate with select clinical parameters, yet viral positivity did not correlate with disease severity. These findings do not support routine viral screening or changes in clinical management for ATH. The role of herpesviruses in ATH pathogenesis warrants further investigation through controlled, longitudinal studies.
- Open Access
- 1 August 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 11205-11216
Multi-Omics Profiling of the 42-Day Infant Gut as a Pilot Predictor of Atopic Dermatitis at One Year: A Birth Cohort Study in China
Background: Early-life gut microbiota and metabolism are increasingly linked to immune development and atopic diseases. However, predictive microbial and metabolic markers present during the neonatal period for later atopic dermatitis (AD) remain poorly defined. This study aimed to identify early-life gut microbiome and metabolite signatures associated with the development of AD by one year of age. Methods: We conducted a prospective birth cohort study in Beijing, China, enrolling 18 infants with fecal samples collected at 42 days of age. Infants were followed for one year and classified into AD (n = 6) or non-AD (n = 12) groups. Fecal samples underwent 16S rRNA gene sequencing and untargeted metabolomic profiling. Key microbial taxa, differential metabolites, and functional pathways were identified and integrated via multi-omics correlation analysis. Results: While overall microbial diversity was similar between groups, Staphylococcus was significantly less abundant in the AD group. Bifidobacterium and Lactobacillus showed strong correlations with lipid- and amino acid-related metabolites, including linoleic acid and N2-acetyl-L-ornithine. AD infants exhibited reduced levels of linoleic acid and choline phosphate. KEGG analysis revealed enrichment in linoleic acid metabolism, sphingolipid signaling, and AGE-RAGE signaling pathways. Integrated network analysis identified microbial–metabolite modules potentially involved in immune and barrier regulation. Conclusion: Multi-omics profiling of the infant gut at 42 days identified microbial and metabolic features associated with later AD development. These findings support the gut–skin axis and suggest potential early-life biomarkers for predicting AD risk and informing targeted prevention strategies.
- 1 August 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 11205-11216
Open AccessMulti-Omics Profiling of the 42-Day Infant Gut as a Pilot Predictor of Atopic Dermatitis at One Year: A Birth Cohort Study in China
Background: Early-life gut microbiota and metabolism are increasingly linked to immune development and atopic diseases. However, predictive microbial and metabolic markers present during the neonatal period for later atopic dermatitis (AD) remain poorly defined. This study aimed to identify early-life gut microbiome and metabolite signatures associated with the development of AD by one year of age. Methods: We conducted a prospective birth cohort study in Beijing, China, enrolling 18 infants with fecal samples collected at 42 days of age. Infants were followed for one year and classified into AD (n = 6) or non-AD (n = 12) groups. Fecal samples underwent 16S rRNA gene sequencing and untargeted metabolomic profiling. Key microbial taxa, differential metabolites, and functional pathways were identified and integrated via multi-omics correlation analysis. Results: While overall microbial diversity was similar between groups, Staphylococcus was significantly less abundant in the AD group. Bifidobacterium and Lactobacillus showed strong correlations with lipid- and amino acid-related metabolites, including linoleic acid and N2-acetyl-L-ornithine. AD infants exhibited reduced levels of linoleic acid and choline phosphate. KEGG analysis revealed enrichment in linoleic acid metabolism, sphingolipid signaling, and AGE-RAGE signaling pathways. Integrated network analysis identified microbial–metabolite modules potentially involved in immune and barrier regulation. Conclusion: Multi-omics profiling of the infant gut at 42 days identified microbial and metabolic features associated with later AD development. These findings support the gut–skin axis and suggest potential early-life biomarkers for predicting AD risk and informing targeted prevention strategies.
- Open Access
- 2 June 2025
- Published by Springer Nature in Virology Journal
- Vol. 22 (1) , 1-26
Herpesvirus-associated diseases: biomarkers and advancements in clinical research
Herpesviruses are responsible for a broad spectrum of diseases that impact various tissues and organs, which could lead to complex pathological manifestations and severe complications. These infections represent a significant burden on global public health. Increasing researches have focused on identifying biomarkers associated with herpesvirus-related diseases and the underlying mechanisms. Studies using clinical samples may better reflect the molecular basis of disease progression, offering new insights into the illustration of disease development. This review provides a comprehensive summary of recent progress in biomarker discovery across a range of disease conditions caused by herpesviruses, highlighting the latest experimental findings and clinical observations, with a particular focus on the potential applications of these biomarkers in clinical settings. Additionally, we discuss the major challenges in the current research of herpesvirus-associated diseases, intending to foster the discovery of novel diagnostic and therapeutic strategies and deepen our understanding of herpesvirus pathogenesis.
- 2 June 2025
- Published by Springer Nature in Virology Journal
- Vol. 22 (1) , 1-26
Open AccessHerpesvirus-associated diseases: biomarkers and advancements in clinical research
Herpesviruses are responsible for a broad spectrum of diseases that impact various tissues and organs, which could lead to complex pathological manifestations and severe complications. These infections represent a significant burden on global public health. Increasing researches have focused on identifying biomarkers associated with herpesvirus-related diseases and the underlying mechanisms. Studies using clinical samples may better reflect the molecular basis of disease progression, offering new insights into the illustration of disease development. This review provides a comprehensive summary of recent progress in biomarker discovery across a range of disease conditions caused by herpesviruses, highlighting the latest experimental findings and clinical observations, with a particular focus on the potential applications of these biomarkers in clinical settings. Additionally, we discuss the major challenges in the current research of herpesvirus-associated diseases, intending to foster the discovery of novel diagnostic and therapeutic strategies and deepen our understanding of herpesvirus pathogenesis.
- Open Access
- 15 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
PRMT3 reverses HIV-1 latency by increasing chromatin accessibility to form a TEAD4-P-TEFb-containing transcriptional hub
Latent HIV-1 presents a formidable challenge for viral eradication. HIV-1 transcription and latency reversal require interactions between the viral promoter and host proteins. Here, we perform the dCas9-targeted locus-specific protein analysis and discover the interaction of human arginine methyltransferase 3 (PRMT3) with the HIV-1 promoter. This interaction reverses latency in cell line models and primary cells from latently infected persons by increasing the levels of H4R3Me2a and transcription factor P-TEFb at the viral promoter. PRMT3 is found to promote chromatin accessibility and transcription of HIV-1 and a small subset of host genes in regions harboring the classical recognition motif for another transcription factor TEAD4. This motif attracts TEAD4 and PRMT3 to the viral promoter to synergistically activate transcription. Physical interactions among PRMT3, P-TEFb, and TEAD4 exist, which may help form a transcriptional hub at the viral promoter. Our study reveals the potential of targeting these hub proteins to eradicate latent HIV-1.
- 15 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Open AccessPRMT3 reverses HIV-1 latency by increasing chromatin accessibility to form a TEAD4-P-TEFb-containing transcriptional hub
Latent HIV-1 presents a formidable challenge for viral eradication. HIV-1 transcription and latency reversal require interactions between the viral promoter and host proteins. Here, we perform the dCas9-targeted locus-specific protein analysis and discover the interaction of human arginine methyltransferase 3 (PRMT3) with the HIV-1 promoter. This interaction reverses latency in cell line models and primary cells from latently infected persons by increasing the levels of H4R3Me2a and transcription factor P-TEFb at the viral promoter. PRMT3 is found to promote chromatin accessibility and transcription of HIV-1 and a small subset of host genes in regions harboring the classical recognition motif for another transcription factor TEAD4. This motif attracts TEAD4 and PRMT3 to the viral promoter to synergistically activate transcription. Physical interactions among PRMT3, P-TEFb, and TEAD4 exist, which may help form a transcriptional hub at the viral promoter. Our study reveals the potential of targeting these hub proteins to eradicate latent HIV-1.
- Open Access
- 28 February 2025
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 14 (1) , 2467773
Paediatric varicella epidemiology in urban Beijing, China, 2014–2023
Data on the clinical epidemiology of varicella in Beijing, China, remain limited. Here, we present an analysis of paediatric varicella cases from 2014 to 2023, including 10,049 cases from two children's hospitals. A gradual decline in the number of varicella cases over this period, with a marked decrease in 2020 coinciding with non-pharmaceutical interventions implemented during the COVID-19 pandemic was observed. Notably, seasonal patterns of varicella incidence weakened after 2019. Although children under four years of age accounted for the majority of cases (57.5%), the proportion of adolescents (13-18 years) increased in 2023. Our findings underscore the need for broader vaccination coverage and enhanced laboratory diagnostics to achieve effective varicella control.
- 28 February 2025
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 14 (1) , 2467773
Open AccessPaediatric varicella epidemiology in urban Beijing, China, 2014–2023
Data on the clinical epidemiology of varicella in Beijing, China, remain limited. Here, we present an analysis of paediatric varicella cases from 2014 to 2023, including 10,049 cases from two children's hospitals. A gradual decline in the number of varicella cases over this period, with a marked decrease in 2020 coinciding with non-pharmaceutical interventions implemented during the COVID-19 pandemic was observed. Notably, seasonal patterns of varicella incidence weakened after 2019. Although children under four years of age accounted for the majority of cases (57.5%), the proportion of adolescents (13-18 years) increased in 2023. Our findings underscore the need for broader vaccination coverage and enhanced laboratory diagnostics to achieve effective varicella control.
- Open Access
- 21 August 2024
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 13 (1) , 2389086
Rising pertussis cases and deaths in China: current trends and clinical solutions
Over the past ten months, the number of reported pertussis cases in China rose from 1,512 in June 2023 to a significant spike in early 2024, reaching 15,275 cases in January. In the subsequent mont...
- 21 August 2024
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 13 (1) , 2389086
Open AccessRising pertussis cases and deaths in China: current trends and clinical solutions
Over the past ten months, the number of reported pertussis cases in China rose from 1,512 in June 2023 to a significant spike in early 2024, reaching 15,275 cases in January. In the subsequent mont...
- Open Access
- 21 November 2023
- Published by Wiley in Pediatric Investigation
- Vol. 7 (4) , 277-289
Multilevel omics for the discovery of biomarkers in pediatric sepsis
Severe sepsis causes organ dysfunction and continues to be the leading reason for pediatric death worldwide. Early recognition of sepsis could substantially promote precision treatment and reduce the risk of pediatric death. The host cellular response to infection during sepsis between adults and pediatrics could be significantly different. A growing body of studies focused on finding markers in pediatric sepsis in recent years using multi‐omics approaches. This narrative review summarized the progress in studying pediatric sepsis biomarkers from genome, transcript, protein, and metabolite levels according to the omics technique that has been applied for biomarker screening. It is most likely not a single biomarker could work for precision diagnosis of sepsis, but a panel of markers and probably a combination of markers detected at multi‐levels. Importantly, we emphasize the importance of group distinction of infectious agents in sepsis patients for biomarker identification, because the host response to infection of bacteria, virus, or fungus could be substantially different and thus the results of biomarker screening. Further studies on the investigation of sepsis biomarkers that were caused by a specific group of infectious agents should be encouraged in the future, which will better improve the clinical execution of personalized medicine for pediatric sepsis.
- 21 November 2023
- Published by Wiley in Pediatric Investigation
- Vol. 7 (4) , 277-289
Open AccessMultilevel omics for the discovery of biomarkers in pediatric sepsis
Severe sepsis causes organ dysfunction and continues to be the leading reason for pediatric death worldwide. Early recognition of sepsis could substantially promote precision treatment and reduce the risk of pediatric death. The host cellular response to infection during sepsis between adults and pediatrics could be significantly different. A growing body of studies focused on finding markers in pediatric sepsis in recent years using multi‐omics approaches. This narrative review summarized the progress in studying pediatric sepsis biomarkers from genome, transcript, protein, and metabolite levels according to the omics technique that has been applied for biomarker screening. It is most likely not a single biomarker could work for precision diagnosis of sepsis, but a panel of markers and probably a combination of markers detected at multi‐levels. Importantly, we emphasize the importance of group distinction of infectious agents in sepsis patients for biomarker identification, because the host response to infection of bacteria, virus, or fungus could be substantially different and thus the results of biomarker screening. Further studies on the investigation of sepsis biomarkers that were caused by a specific group of infectious agents should be encouraged in the future, which will better improve the clinical execution of personalized medicine for pediatric sepsis.
- Open Access
- 23 June 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1
Author Correction: Transcription tuned by S-nitrosylation underlies a mechanism for Staphylococcus aureus to circumvent vancomycin killing
- 23 June 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1
Open AccessAuthor Correction: Transcription tuned by S-nitrosylation underlies a mechanism for Staphylococcus aureus to circumvent vancomycin killing
- Open Access
- 21 April 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-14
Transcription tuned by S-nitrosylation underlies a mechanism for Staphylococcus aureus to circumvent vancomycin killing
Treatment of Staphylococcus aureus infections is a constant challenge due to emerging resistance to vancomycin, a last-resort drug. S-nitrosylation, the covalent attachment of a nitric oxide (NO) group to a cysteine thiol, mediates redox-based signaling for eukaryotic cellular functions. However, its role in bacteria is largely unknown. Here, proteomic analysis revealed that S-nitrosylation is a prominent growth feature of vancomycin-intermediate S. aureus. Deletion of NO synthase (NOS) or removal of S-nitrosylation from the redox-sensitive regulator MgrA or WalR resulted in thinner cell walls and increased vancomycin susceptibility, which was due to attenuated promoter binding and released repression of genes involved in cell wall metabolism. These genes failed to respond to H2O2-induced oxidation, suggesting distinct transcriptional responses to alternative modifications of the cysteine residue. Furthermore, treatment with a NOS inhibitor significantly decreased vancomycin resistance in S. aureus. This study reveals that transcriptional regulation via S-nitrosylation underlies a mechanism for NO-mediated bacterial antibiotic resistance.
- 21 April 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-14
Open AccessTranscription tuned by S-nitrosylation underlies a mechanism for Staphylococcus aureus to circumvent vancomycin killing
Treatment of Staphylococcus aureus infections is a constant challenge due to emerging resistance to vancomycin, a last-resort drug. S-nitrosylation, the covalent attachment of a nitric oxide (NO) group to a cysteine thiol, mediates redox-based signaling for eukaryotic cellular functions. However, its role in bacteria is largely unknown. Here, proteomic analysis revealed that S-nitrosylation is a prominent growth feature of vancomycin-intermediate S. aureus. Deletion of NO synthase (NOS) or removal of S-nitrosylation from the redox-sensitive regulator MgrA or WalR resulted in thinner cell walls and increased vancomycin susceptibility, which was due to attenuated promoter binding and released repression of genes involved in cell wall metabolism. These genes failed to respond to H2O2-induced oxidation, suggesting distinct transcriptional responses to alternative modifications of the cysteine residue. Furthermore, treatment with a NOS inhibitor significantly decreased vancomycin resistance in S. aureus. This study reveals that transcriptional regulation via S-nitrosylation underlies a mechanism for NO-mediated bacterial antibiotic resistance.
- Open Access
A unified classification system for HIV-1 5’ long terminal repeats
The HIV-1 provirus mainly consists of internal coding region flanked by the 2 same long terminal repeats (LTRs) at each terminus. The LTRs play important roles in HIV-1 reverse transcription, integration, and transcription by the association with host factors. However, despite of the significant study advances of the internal coding regions of HIV-1 by using definite reference classification, there are no systematic classifications for HIV-1 5’ LTRs, which hinders our elaboration on 5’ LTR and a better understanding of the viral origin, spread and therapy. Here, by analyzing all available resources of 5’ LTR sequences in public databases following 4 recognized principles for the reference classification, 83 representatives and 14 consensus sequences were identified as representatives of 2 groups, 6 subtypes, 6 sub-subtypes, and 9 CRFs. To test the reliability of our established classification system, the constructed references were applied to identify the 5’ LTR assignment of the 22 clinical isolates in China. The results revealed that 16 out of 22 tested strains showed a consistent subtype classification with the previous LTR-independent classification system. However, 6 strains, for which recombination events within 5’ LTR were demonstrated, unexpectedly showed a different subtype classification, leading a significant change of binding sites for important transcription factors including SP1, p53, and NF-κB. The binding change of these transcriptional factors would probably affect the transcriptional activity of 5’ LTR. This study established a unified classification system for HIV-1 5’ LTRs, which will facilitate HIV-1 characterization and be helpful for both basic and clinical research fields. IMPORTANCE Here, a scientific, reliable, and usable classification system based on the 5’ LTR sequences was established, which will allow us to effectively facilitate the precise typing of HIV-1 strains. This classification system was applied to 22 HIV-1 strains circulating in China, we found that 6 out of 22 strains analyzed, belonged to a different subtype when our results were compared to those obtained with the previous LTR-independent classification system. Thus, these data demonstrated that our classification method could greatly improve the HIV-1 subtype classification. We found that 6 5’ LTR sequences showed recombination events, leading to a significant exchange of the binding sites of transcriptional factors. Thus, this work established a comprehensive HIV-1 5’ LTR classification system, which will help the scientific community to precisely characterize HIV-1 variants, and better understand the origin and spread of HIV-1 strains, and it also may be helpful for pathogenicity and transmissibility evaluation studies.
Open AccessA unified classification system for HIV-1 5’ long terminal repeats
The HIV-1 provirus mainly consists of internal coding region flanked by the 2 same long terminal repeats (LTRs) at each terminus. The LTRs play important roles in HIV-1 reverse transcription, integration, and transcription by the association with host factors. However, despite of the significant study advances of the internal coding regions of HIV-1 by using definite reference classification, there are no systematic classifications for HIV-1 5’ LTRs, which hinders our elaboration on 5’ LTR and a better understanding of the viral origin, spread and therapy. Here, by analyzing all available resources of 5’ LTR sequences in public databases following 4 recognized principles for the reference classification, 83 representatives and 14 consensus sequences were identified as representatives of 2 groups, 6 subtypes, 6 sub-subtypes, and 9 CRFs. To test the reliability of our established classification system, the constructed references were applied to identify the 5’ LTR assignment of the 22 clinical isolates in China. The results revealed that 16 out of 22 tested strains showed a consistent subtype classification with the previous LTR-independent classification system. However, 6 strains, for which recombination events within 5’ LTR were demonstrated, unexpectedly showed a different subtype classification, leading a significant change of binding sites for important transcription factors including SP1, p53, and NF-κB. The binding change of these transcriptional factors would probably affect the transcriptional activity of 5’ LTR. This study established a unified classification system for HIV-1 5’ LTRs, which will facilitate HIV-1 characterization and be helpful for both basic and clinical research fields. IMPORTANCE Here, a scientific, reliable, and usable classification system based on the 5’ LTR sequences was established, which will allow us to effectively facilitate the precise typing of HIV-1 strains. This classification system was applied to 22 HIV-1 strains circulating in China, we found that 6 out of 22 strains analyzed, belonged to a different subtype when our results were compared to those obtained with the previous LTR-independent classification system. Thus, these data demonstrated that our classification method could greatly improve the HIV-1 subtype classification. We found that 6 5’ LTR sequences showed recombination events, leading to a significant exchange of the binding sites of transcriptional factors. Thus, this work established a comprehensive HIV-1 5’ LTR classification system, which will help the scientific community to precisely characterize HIV-1 variants, and better understand the origin and spread of HIV-1 strains, and it also may be helpful for pathogenicity and transmissibility evaluation studies.